The aim of the study was to assess the additive prognostic value of coronary flow velocity reserve (CFVR) alongside wall motion analysis during exercise echocardiography in patients with known or suspected coronary artery disease (CAD).
Introduction
Stress echocardiography in different guises is a well-established method with high diagnostic and prognostic value. In patients with known or suspected coronary artery disease (CAD), exercise or pharmacological echocardiography predicts cardiac events with great accuracy. 1 -3 It is also effective in cases when coronary arteries are without significant stenoses according to coronary angiography. 4 Despite these known facts, some patients with negative stress tests may have a poor prognosis that was previously shown in stress echocardiography with dipyridamole. 5, 6 The added prognostic role of impairment of coronary flow velocity reserve (CFVR) in the left anterior descending artery (LAD) alongside regional wall motion analysis in persons with normal and also abnormal dipyridamole stress echo has been demonstrated. 7 However, when a patient is able to perform routine daily activities without difficulty, exercise testing to provoke ischaemia is preferred, because it can often provide higher physiological stress than would be achieved by pharmacological testing. 8 Moreover, the sensitivity of the conventional dipyridamole test is either lower than the sensitivity of exercise echocardiography 9 or similar to the exercise ECG test. 10 Also coronary artery flow parameters may be different during exercise in comparison to reaction to pharmacological agents, so it has previously been unknown if there is additive prognostic value in CFVR for exercise tests. The aim of the study was to assess the additive prognostic value of CFVR alongside wall motion analysis during exercise echocardiography in patients with known or suspected CAD.
Methods Patients
We prospectively screened 917 consecutive outpatients with known (56%) or suspected CAD (44%) who were referred for exercise echocardiography for diagnostic purposes or for stratification of risk in accordance with their doctors' clinical decisions. Patients were enrolled in the study over 9 months. One hundred and eight patients were overlapped with the cohort of the previous work, which had different aims.
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Seven hundred and thirty-nine patients of the whole group (81%) had satisfactory imaging of LAD flow during test. Therefore, feasibility of LAD flow assessment was 81%. The group with successful LAD flow assessment was of similar age to that without LAD flow assessment (56 + 9 vs. 57 + 8 years old, P ¼ 0.11). The groups had the same sex distribution (65 vs. 62% men, P ¼ 0.43), a similar proportion of patients with arterial hypertension (80 vs. 80%, P ¼ 0.90), and a similar proportion of smokers (21 vs. 20%, P ¼ 0.73). However, there was a smaller proportion of patients with diabetes mellitus among the group with good visualization of LAD (14 vs. 22%, P , 0.02).
Fifty of these patients were lost to follow-up (7%). Thus, 689 patients comprised the final study group. There were 449 males (65%) and 240 females (35%). The average age of the group was 56 + 9 years. The patients gave their written informed consent, and the investigation was approved by an ethics committee. All patients were followed up for a median of 36.6 months (first quartile 36.5, third quartile 36.8).
Resting and stress echocardiography
Transthoracic echocardiographic studies were performed with a commercially available ultrasound machine (GE Healthcare, Liestal, Switzerland, Vivid System 7 Dimension) equipped with M4S multifrequency phased-array sector scan probe with second harmonic technology. Ejection fraction (EF) was measured and calculated using the biplane method of disks (modified Simpson's rule). All patients performed a supine bicycle symptoms-limited test with the conventional visual assessment of wall motion abnormalities using e-Bike EL&BP (General Electric, USA). The initial power output was 50 W, followed by increases of 25 W every 2 min until standard end-points were reached. 12 ECG and arterial pressure were monitored during the test. All studies were continuously recorded on a hard drive and a DVD for offline analysis. Images were obtained in the four-and two-chamber apical views, and the long-and short-axis parasternal views. Echocardiographic images were acquired at rest and consistently at all stages of test activity. Post-stress images, analogous to those at rest, were obtained as soon as possible after stopping exercise and not later than 60 s. The images at rest, during stress, and after stopping were compared side by side in a cine-loop display. Regional left ventricular function was assessed using a standardized 17-segment model. 13 All the patients performed the exercise test without b-blockers.
Transthoracic examination of LAD flow
Examination of the anatomical course of the coronary arteries was performed using colour Doppler mapping. The velocity scale of colour Doppler was set to 0.24 m/s at rest and to 0.41 m/s at the peak of exercise. However, this was actively changed to provide optimal images. Pulsed wave Doppler registered blood flow velocity patterns using a sample volume (2 -3.0 mm) placed on the colour signal. The ultrasound beam was aligned in parallel to vessel flow as much as possible. The LAD was examined from a low left parasternal position to a modified apical two-, four-or five-chamber position at varying levels using views in the anterior interventricular groove. Coronary flow Doppler images were acquired before and during exercise in the same part of the arterythe middle section of the LAD (Figure 1) . The diastolic peaks of coronary flow velocities were measured ( Figure 2 ). Differences between peak-of-exercise velocities and rest velocities (DV ) were calculated, as well as a CFVR-the ratio of peak stress velocity to rest velocity. All measurements were obtained offline blind to clinical characteristics, wall motion abnormalities, and angiographic data. The observer who measured coronary parameters did not see the motion of the heart at rest and during exercise; the measurement of the velocity was performed using only pulsed wave Doppler images.
Follow-up data
Outcomes were determined through patient interviews at the clinic, hospital chart reviews, and telephone interviews with the patient or his/her close relative. Of the clinical events recorded during the follow-up, death, non-fatal myocardial infarction, cardiac arrest with cardiopulmonary resuscitation, and myocardial revascularization were defined as major adverse cardiac events (MACE). All the events were confirmed by medical records. To avoid the misclassification of the cause of death, 14 overall mortality was considered. Myocardial infarction was defined by criteria described previously. 15 Myocardial revascularization constituted percutaneous coronary intervention with stenting (PCI) or/and coronary artery bypass graft surgery (CABG).
Statistics
Continuous variables were described by means and standard deviations with categorical data being expressed in percentages. For multiple comparisons, ANOVA was performed. Kaplan-Meier survival curves were used. Comparison of proportions was performed with the Pearson x 2 test and Fisher's exact test. Receiver operating characteristic (ROC) analysis was used to assess the accuracy for predicting MACE.
To adjust for several risk factors, multivariable Cox analysis was performed. The following categorical and continuous data were accounted for in the Cox analysis: age, weight, the presence of arterial hypertension, functional class of angina, the fact of previous myocardial infarction, previous PCI, previous CABG, and the presence of diabetes; maximal physical capacity, maximal heart rate, and maximal blood pressure during exercise test, the presence of significant ST depression and the fact of angina during stress test; EF, the presence of wall motion abnormalities in the left descending artery, left circumflex coronary artery, and right coronary artery territories before and after exercise, the presence of ischaemia during exercise identified by echo; diastolic velocity of LAD flow at rest, at peak of exercise, the differences between peak-ofexercise velocities and rest velocities (DV ), and CFVR. 
Results

Patients
General characteristics of the study group are shown in Table 1 .
Forty per cent of the study population had typical angina (30% without previous myocardial infarction, 6% with a history of myocardial infarction after PCI, and 4% with a history of myocardial infarction and limited functional capacity because of angina). Seven per cent of patients had a history of myocardial infarction with atypical chest pain, 24% of patients had a history of myocardial infarction without any present chest pain and were referred for stress echocardiography for strategic assessment. Twenty-seven per cent had atypical chest pain with an intermediate pretest probability of CAD and 2% of patients had atypical chest pain with a low pretest probability of CAD, but they were referred to stress echocardiography because of ST-T segment changes and the presence of other risk factors (high level of cholesterol, smoking, and diabetes mellitus).
Stress echocardiography
All the patients completed a satisfactory bicycle test. There were no severe adverse events during and after exercise. The majority of the patients (242 persons-35%) reached the target heart rate, 113 (16%) patients suffered angina during exercise, 111 (16%) experienced fatigue, 68 (10)% had severe shortness of breath, 60 (9%) stopped the test due to significant worsening of left ventricle contraction, 39 (6%) presented significant ECG ST depressions as a reason for stopping, 31 (4%) presented different types of arrhythmias: frequent ventricular premature beats, supraventricular, or nonsustained ventricular tachycardias, 20 (3%) had an abnormal high blood pressure response, and 5 persons (1%) had a drop in systolic blood pressure of .10 mmHg from baseline pressure. The test was positive for wall motion criteria in 359 patients (52%). There was a significant correlation between the peak rate pressure product and CFVR: r ¼ 0.41, P , 0.0001.
Follow-up and end-points
During a follow-up of 36.6 months, 15 deaths occurred. There were 200 patients with major adverse events (MACE): 15 deaths, 17 nonfatal myocardial infarctions (11 of them also had PCI or/and CABG), and 179 patients underwent revascularization (79 had coronary artery bypass grafting, 96 had percutaneous coronary stenting, and 4 had both procedures performed). The groups of dead and surviving patients showed differences in the proportion of subjects with wall motion abnormalities in LAD zones at rest (40 vs. 19%, P , 0.04), of subjects with wall motion abnormalities in left circumflex territories at rest (40 vs. 13%, P , 0.003), of subjects with wall motion abnormalities in right coronary artery territories at rest (53 vs. 29%, P , 0.04), and of subjects with wall motion abnormalities in left circumflex territories during exercise (67 vs. 37%, P , 0.03). The proportions of men/women, patients with the presence of arterial hypertension, different functional class of angina, with previous myocardial infarction, previous PCI, previous CABG, the presence of diabetes, left bundle branch block, the presence of significant ST depression, incidence of angina during the stress test, and the presence of wall motion abnormalities in the left descending and right coronary artery territories during exercise were similar in these groups. Among all the continuous variables, there was a significant difference in average value of maximal physical capacity (85 + 34 vs. 113 + 41 Wt, P , 0.008), EF (54 + 15 vs. 63 + 11%, P , 0.05), DV (9 + 30 vs. 31 + 25 cm/s, P , 0.003), and CFVR (1.4 + 0.7 vs. 2.0 + 0.8, P , 0.03) in the dead and surviving groups of patients.
The differences between groups with and without MACE are presented in Table 2 .
In multivariable analysis, the positivity for regional wall motion abnormalities during test (OR 0.10, 95% CI 0.04 -0.25, P , 0.000), wall motion abnormalities of left circumflex territories during test (OR 0.29, 95% CI 0.18 -0.49, P , 0.000), previous PCI (OR 0.38, 95% CI 0.16 -0.90, P , 0.003), male sex (OR 0.44, 95% CI 0.27 -0.71, P , 0.0009), CFVR in LAD (OR 0.53, 95% CI 0.35 -0.79, P , 0.0001), wall motion abnormalities of LAD territories at rest Prognosis of coronary flow during exercise echo (OR 0.97, 95% CI 0.95-0.99, P , 0.02), and heart rate reached during exercise (OR 0.98, 95% CI 0.96 -0.99, P , 0.02) were independent prognostic predictors of MACE.
ROC analysis demonstrated that the best cut-off point for CFVR was 1.89. It could significantly predict death with sensitivity 91% and specificity 53%, area under ROC curve 0.71, P , 0.02 ( Figure 3A) . It predicted death/myocardial infarction with sensitivity 86% and specificity 54%, area under ROC curve 0.71, P , 0.0002 ( Figure 3B) , and death/myocardial infarction/CABG with sensitivity 81%, specificity 72%, area under ROC curve 0.82, P , 0.0001 ( Figure 3C) .
So value lower than 1.89 was used as abnormal level of CFVR. The 36.6 months' survival free from MACE showed a significantly better outcome for those patients with negative exercise stress echocardiography test (ESE) by wall motion criteria and with normal CFVR (Figure 4) , whereas the worst outcome was observed in patients with positive ESE and impaired CFVR. The mortality rate was significantly higher in the group with positive stress test and low CFVR in comparison to positive test and normal CFVR, just as in the comparison between the group with negative test and low CFVR and the group with negative test and normal CFVR (4.6 vs. 0 vs. 2.5 vs. 0.5%, respectively; P , 0.02).
Discussion
Exercise echocardiography is an essential clinical tool providing useful diagnostic and prognostic information. This type of provocative test is widely used, because it is physiological, simple, and safe. Coronary flow velocity reserve of LAD 1.5 + 0.6 2.1 + 0.8 ,0.0001 MACE, major adverse cardiac events; BMI, body mass index; AH, arterial hypertension; MI, myocardial infarction; EF, ejection fraction; LAD, left anterior descending artery; DV, the differences between peak-of-exercise velocities and rest velocities; NS, not significant. with known or suspected CAD. Measuring CFVR during the same tests as wall motion assessment can be helpful in identifying patients at higher risk of subsequent adverse events. A reduced CFVR during exercise is an additional parameter to be considered in the risk stratification of the stress echocardiographic response, whereas patients with a negative test and normal CFVR have a favourable outcome. The revascularizations were also included as a prognostic end-point for MACE, because they significantly decrease the rate of myocardial infarction and mortality. If they were excluded, we would acquire a lower rate of adverse events (myocardial infarction and mortality) than in a real situation where the patients were without revascularization. However, CFVR was a significant predictor of death, death/myocardial infarction, and death/myocardial infarction/ CABG. Previous studies have shown the potential and diagnostic value of recording coronary flow parameters during exercise tests for LAD narrowing. 11, 16 Quantitative information of coronary flow during stress echocardiography provides objective information that depends less on expert interpretation.
Previous works with vasodilators have demonstrated the incremental diagnostic 17 -19 and additive prognostic value of CFVR during dipyridamole tests. 5 -7 Reduced CFVR was an additional parameter in the risk stratification of the stress echocardiographic response. Rigo et al. identified that a negative test with normal CFVR confers a benign prognosis, whereas patients with the negative test and reduced CFVR have 15% spontaneous events a year (death or worsening of clinical status) and .3% myocardial infarction a year in consecutive in-patients with known or suspected CAD. CFVR also provides independent prognostic information in diabetic and non-diabetic patients and in patients with negative dipyridamole stress echocardiography by wall motion criteria. 20 The incremental prognostic value of recording coronary flow parameters during vasodilator tests was also shown for patients with left bundle branch block, 21 for octogenarians, 22 and for people with idiopathic dilated cardiomyopathy. 23 However, the sensitivity of the conventional dipyridamole test is significantly lower than the sensitivity of exercise echocardiography, 9 so it was unclear whether CFVR would provide additional information for stratification of patients during the exercise test. The present work shows that CFVR could also be used in such stress echocardiography, because this parameter divides both groups of patients with positive and negative tests by wall motion conventional analysis into subgroups with significantly differing prognoses. Moreover, this kind of test has definite advantages, because it is safe, physiological, easy for the patient, and does not require medication. The value of the CVFV cut-off was lower in comparison to the pharmacological test. This study was smaller than analogous ones with pharmacological agents, but significant differences were observed in all the subgroups. The individuals with the ischaemic exercise test and reduced CFVR had the worst prognosis: 60% of Prognosis of coronary flow during exercise echo patients from this group experienced MACE in the 3-year period. A negative test with normal CFVR confers a benign prognosis, with ,1% of subjects experiencing MACE per year. Watchful surveillance, probably with repeated tests, is recommended in those with a negative test and abnormal CFVR, as .2% of these patients had MACE within a year.
Study limitations
It should be noted that this was a single-centre study.
The CFVR was sampled only on LAD; it was technically difficult to combine wall motion assessment with measurement of coronary flow velocity in more than one vessel. All-cause mortality was also employed in the statistical analysis.
Conclusion
Coronary flow reserve on LAD territory is feasible in expert hands. The coronary flow velocity parameters give additive prognostic information to wall motion abnormalities during routine supine bicycle exercise echocardiography. Whenever suitable technology and dedicated expertise are available, performing imaging exercise stress echocardiography with coronary flow velocity analysis during the same tests can be recommended for prognostic purposes.
